哪个是最具成本效益的抗发作药物用于焦点的初始单疗法?
Yani Hu1, Shunan Chen1,2, Fengqian Mao1,2
1Department of Pharmacy, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Epilepsia
|January 22, 2025
概括
卡巴马西平 (CBZ) 单疗法是最具成本效益的焦点的第一线治疗方法. 虽然大多数传统的抗发作药物 (ASM) 比较新的选择更具成本效益,但oxcarbazepine (OXC) 是一个显著的例外.
科学领域:
- 药物经济学 药物经济学
- 神经学 神经学
- 治疗的方法 治疗
背景情况:
- 对焦性单疗法的终身成本效益的直接比较是有限的.
- 许多抗发作药物 (ASM) 可用于焦点单疗法.
研究的目的:
- 为了比较新的和传统的ASM作为新诊断的焦点的第一线单一治疗的终身成本效益.
- 从社会角度来看,在美国确定最具成本效益的治疗策略.
主要方法:
- 使用马尔科夫模型来评估10种ASM的生命周期成本效益,并将lacosamide (LCM) 作为对照剂.
- 有效性,成本和质量调整寿命年 (QALY) 的数据来源于已发表的文献.
- 进行了敏感性和场景分析,以解决参数不确定性.
主要成果:
- 与酸 (VPA), levetiracetam (LEV), gabapentin (GBP), topiramate (TPM) 和lamotrigine (LTG) 相比,卡巴马泽平 (CBZ) 是最便宜和最有效的选择.
- 氧化碳bazepine (OXC),phenytoin (PHT),phenobarbitone (PHB),LCM和zonisamide (ZNS) 显示出比CBZ更高的有效性,具有不同的增量成本效益比率 (ICER).
- 当考虑仿制药时,PHT,OXC和CBZ成为前三大最具成本效益的选择.
结论:
- 对于新诊断的焦点来说,CBZ单疗是最佳的成本效益选择.
- 大多数传统的ASM比新的ASM更具成本效益,OXC是一个显著的例外.
- 这项研究为治疗决策提供了宝贵的见解,平衡焦点管理中的成本和有效性.
更多相关视频
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.1K
06:58Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
19.0K
相关概念视频
01:08Antiepileptic Drugs: Sodium Channel Blockers
367
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
367
01:20Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
01:17Antiepileptic Drugs: Calcium Channel Blockers
299
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
299
01:14Antiepileptic Drugs: Glutamate Antagonists
273
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
273
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
316
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
316
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
224
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
224